Trends in implantable cardioverter defibrillator and cardiac resynchronisation therapy lead parameters for patients with arrhythmogenic and dilated cardiomyopathies-Reference-Cited by-同舟云学术

Trends in implantable cardioverter defibrillator and cardiac resynchronisation therapy lead parameters for patients with arrhythmogenic and dilated cardiomyopathies

Published:2019-03 Issue:2 Volume:19 Page:49-54
ISSN:0972-6292
Container-title:Indian Pacing and Electrophysiology Journal
language:en
Short-container-title:Indian Pacing and Electrophysiology Journal

Author:

Lane Jem D.,Whittaker-Axon Sarah,Schilling Richard J.,Lowe Martin D.

Publisher

Elsevier BV

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference17 articles.

1. Arrhythmogenic right ventricular cardiomyopathy: severe structural alterations are associated with inflammation;Campuzano;J Clin Pathol,2012

2. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L, Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators (2005) the effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med;352:1539–1549.

3. Arrhythmogenic right ventricular cardiomyopathy;Corrado;N Engl J Med,2017

4. Long-term right ventricular implantable cardioverter-defibrillator lead performance in arrhythmogenic right ventricular cardiomyopathy;Herman;Heart Rhythm,2016

5. Right ventricular pacing and sensing function in high posterior septal and apical lead placement in cardiac resynchronization therapy;Kristiansen;Indian Pacing Electrophysiol J,2012

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing RV lead position in RV cardiomyopathy: Are we there yet?;Indian Pacing and Electrophysiology Journal;2019-03